STM
Journals
—
Open Access
Special Issue
Topic

Breast cancer immunotherapy and targeted therapy

Guest Editor:

        • Abstract Submission Deadline : 30/11/2023

        Manuscript Submission Deadline : 25/12/2023

        [This article belongs to Special Issue Breast cancer immunotherapy and targeted therapy under section rrjomst, rrjomst in (rrjomst, rrjomst)]

        Special Issue Description

        Worldwide, breast cancer still ranks as one of the leading causes of cancer death. The numerous immunotherapeutic and targeted therapy approaches currently under investigation offer hope for a better prognosis for patients with breast cancer.These methods include using immunotherapeutic checkpoint inhibitors in approved clinical settings to treat metastatic triple-negative breast cancer that has PD-L1 expression, as well as BRCA-deficient breast malignancies with poly (ADP-ribose) polymerase (PARP) inhibitors. Although encouraging, these focused techniques have only had limited success, necessitating further improvements in patient classification and innovative drug/target combinations. We welcome papers on breast cancer that look at the many facets of immunotherapeutic and targeted therapy approaches. Original research articles and reviews are encouraged for this topic. Pre-clinical and clinical studies that look at the different facets of immunotherapeutic and targeted therapeutic strategies, as well as cutting-edge drug delivery techniques, may be included in—but are not limited to—research on breast cancer.

        Editor Keywords

        Breast cancer, Immunotherapy, Immune checkpoint blockade, Targets, Inhibitors, Precision medicine, Cancer nanomedicine

        Manuscript Submission information

        Manuscripts should be submitted online by registering and logging in to this link. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed.
        Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent on email address:[email protected] for announcement on this website.

        Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

        Participating journals:

        Journal Name

        Research & Reviews : Journal of Medical Science and Technology, Research & Reviews : Journal of Medical Science and Technology

        Abbrivation

        rrjomst, rrjomst

        ISSN

        2319-3417, 2319-3417

        Since

        2012

        APC

        1000  $